The resistance of Ralstonia eutropha-like strain CH34 (Alcaligenes eutrophus CH34) against multiple heavy metals can be regarded as a phenomenon in its own right (15) and has found increasing applications within the field of environmental technology (29) . The metal resistance determinants, which are localized predominantly on either of the two indigenous megaplasmids pMOL28 (15, 28) and pMOL30 (15) , have been recently reviewed by Taghavi et al. (27) . One important application has been the development of metal-specific biosensors based on in vivo and in vitro gene fusions of CH34 heavy metal resistance determinants. This was possible only through a detailed knowledge of the regulation of the metal resistances at the molecular level (2) .
The cnr operon, located on pMOL28 (13, 28) , encodes a phenotype of inducible resistance to 5 mM Co 2ϩ and 3 mM Ni 2ϩ in minimal medium. Resistance is mediated by an intricate coordination between the genes of the regulatory locus, cnrYXH, located upstream of the structural locus, cnrCBA (13) . The latter encodes a three-component cation/proton antiporter (4), whose topological orientation in the membrane has been elucidated largely by comparison with the well-studied czc (cadmium-zinc-cobalt resistance) system (3, 17, 21) , with which it shares close homology at the protein level (18, 20) .
Despite the strong similarity between the structural resistance genes of the czc (17, 18) , czr (9) , sil (8) , cnr (13) , and ncc (25) operons, the regulation of both cnr and ncc (nickel resistance determinants) differs greatly from that of the other three-component-system-based heavy metal resistance operons. The cnr and ncc operons share an average of 66% identity in their regulatory loci and 79% in their structural loci. For cnr, regulation requires the activities of at least three genes, cnrYXH. Until now, the gene products of the regulatory locus have remained elusive. Only CnrH shares a close similarity (32%) with a known gene product, namely, E of Escherichia coli, an alternative 70 -like sigma factor of the extracytoplasmic function (ECF) family (14, 16, 22) . CnrY and CnrX, however, show no homology to known proteins, and therefore their functional roles in vivo have remained open to debate. In this paper, we report the preliminary characterization of the Cnr regulatory proteins, through cloning and isolation from E. coli overexpression systems, and the molecular characterization of a spontaneous cnr mutant harboring zinc resistance. Furthermore, we identified promoter regions within the regulatory locus by use of transcriptional fusions with reporter bioluminescence genes and examined their heavy metal-dependent activity.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . R. eutropha-like strains were grown in either 869 medium (15) or Tris-buffered 284 medium with 0.2% (wt/vol) gluconate (15) as a carbon source. Bioluminescence assays were carried out in either 284-gluconate liquid medium or RM medium (284 medium supplemented with 0.1% [wt/vol] gluconate, MOPS [morpholinepropanesulfonic acid], and beta-glycerol phosphate replacing Tris and inorganic phosphate, respectively) (2) . For E. coli, 869 medium supplemented with antibiotics was used for propagation, while Luria broth (LB) supplemented with antibiotics and/or 2% (wt/ vol) glucose was used in protein overexpression cultures. Antibiotic concentrations were 20 g of tetracycline (TET) per ml and 100 g of ampicillin (AMP) per ml. NiCl 2 and CoCl 2 were used for lux induction experiments. R. eutropha and E. coli strains were grown at 30 or 37°C, respectively, unless stated otherwise.
Genetic techniques. Standard molecular genetic techniques were used (23) . The pMOL28 plasmid (15) was used as the source for the cnr genes and was extracted from AE126 by the procedure of Taghavi et al. (26) . Electroporation (26) was used to introduce plasmid DNA into R. eutropha and E. coli.
Construction of Cnr protein overexpression clones. The cnrY gene was cloned in its two possible open reading frames (ORFs) (13) . The cnrYa ORF (positions 970 to 1266, according to the numbering of Liesegang et al. [13] ) was PCR amplified as an NcoI-BamHI fragment from pMOL28, using 5Ј-GATCTCCAT GGAGGTTTGCCACGGC-3Ј as the upstream primer and 5Ј-GCGGCAAGG ATCCTGTCAGC-3Ј as the downstream primer. The resulting fragment spanned the region from position 962 to 1747 of the cnr sequence. The cnrYb ORF (positions 982 to 1270) was amplified as an NcoI-HindIII fragment with the upstream and downstream primers 5Ј-GTTTGCCATGGCAGACGTGGAAG A-3Ј and 5Ј-ATGGCAAGCTTGCCGACGCC-3Ј, respectively, spanning positions 981 to 1516. The inserts were cloned into the expression vector pTrc99A, linearized with either NcoI-BamHI or NcoI-HindIII. The cnrX gene (positions 1272 to 1727) was cloned as an RcaI-BamHI fragment using the primers 5Ј-CG GTAAATCATGAAATCTCGT-3Ј (upstream) and 5Ј-GCGGCAAGGATCCT GTCAGC-3Ј (downstream) into pTrc99A, linearized with NcoI and BamHI. Following ligation, plasmid constructs were transformed into E. coli JM105 and selected on LB-AMP. Positive transformants were sequenced to ensure the in-frame insertion of the cloned fragments within the expression vector.
Expression of cnr regulatory genes in a cell-free system. The protein expression of pTrcCnrX, pTrcCnrYa, and pTrcCnrYb in E. coli JM105 was tested in a cell-free system. Plasmid DNAs (4 g) of the clones were used as templates (in both linearized and circularized forms) in an in vitro coupled transcriptiontranslation protocol, using the Promega (Madison, Wis.) E. coli S30 Extract System For Linear Templates kit, as specified by the manufacturer. L- [4,5- 3 H]-Leucine (Amersham Pharmacia Biotech, Rainham, United Kingdom) was used to label nascent polypeptides. The translation products were separated on a 16.5% T, 6% C Tricine sodium dodecyl sulfate (SDS)-polyacrylamide gel (24) and visualized by autoradiography.
14 C-labeled protein markers (Amersham Pharmacia Biotech) were included as standards. Expression and production of cnrX gene products in E. coli. Overnight cultures of E. coli(pTrcCnrX) were diluted 100-fold in 5 ml of LB-AMP and grown to an optical density at 600 nm (OD 600 ) of 1.0. IPTG (isopropyl-␤-D-thiogalactopyranoside) (1 mM) was added to induce protein overexpression for 4 to 5 h. The cells were harvested and lysed by sonication in lysis solution (25 mM Tris [pH 7.5], 0.1 M NaCl, 1 mM EDTA, 15% [vol/vol] glycerol) with 0.1 mg of phenylmethylsulfonyl fluoride added as a protease inhibitor. The pellet fraction was collected following centrifugation at 18,000 rpm for 10 min (Sorvall centrifuge, SS34 rotor) and solubilized in 0.25% (wt/vol) Thesit (Roche Diagnostics, Brussels, Belgium) plus 10 mM EDTA, followed by incubation at 4°C for 30 min. The samples were centrifuged at 40,000 rpm for 2 h at 4°C, using a Beckman ultracentrifuge. The supernatant was collected, mixed with Laemmli loading buffer, fractionated on a 16.5% Tricine SDS-polyacrylamide gel (24) , and visualized with Coomassie blue R-250.
Construction of PhoA (alkaline phosphatase) fusions with CnrX. A gene fusion between the nucleotide sequence of cnrXЈ encoding the first 27 amino acids of CnrX (MMKSRT . . . . AAWL) and that of the ORF encoding the mature form of alkaline phosphatase (phoA) was constructed in vitro. In this construct, transcription of cnrX and that of phoA are coupled and directed from the pTrc promoter, resulting in a hybrid CnrX-PhoA fusion protein. The pTrc promoter together with cnrX were obtained by PCR amplification of pTrcCnrX using the downstream primer 5Ј-CGCGAATGGATCCGCTCATGTTTGAC-3Ј (BamHI site) and the upstream primer 5Ј-TGCGAGTAGATCTGCCATGCC GC-3Ј (BglII site). The cnrXЈ fragment was cloned as a BamHI-BglII insert in the BglII-linearized and dephoshorylated plasmid pGV4218 (5, 19) . The hybrid plasmid was used to transform E. coli DH5␣. Transconjugants were selected directly on LB plates with 25 g of kanamycin per ml, 100 g of AMP per ml, 1 mM IPTG, and 0.5 mg of XP (5-bromo-4-chloro-3-indolylphosphate, 4-toluidine salt) (Boehringer Mannheim) per ml. This resulted in two plasmids, pCnrXphoA1 and pCnrXphoA2, having the pTrc-cnrXЈ fragment cloned with phoA in the same and opposite orientations, respectively. The orientations of the cloned inserts were verified by PCR (5), while the structural integrity of the constructs was confirmed by sequence analysis. Constructs with plasmid pCnrXphoA1 formed small, dark blue colonies (PhoA ϩ ), while PhoA Ϫ transconjugants with the insert in the opposite orientation formed larger, light green colonies with a white halo or simply uniform white colonies.
Construction of histidine-tagged fusion proteins. Both cnrX and cnrH were cloned as tagged fusions incorporating an N-terminal His tag. For the construction of pRSETCnrX, the cnrX ORF was amplified from pMOL28 as a BamHIPstI fragment with downstream and upstream primers 5Ј-TTTGGATCCATGA TGAAATCTCGTACCCGACGG-3Ј and 5Ј-TTTCCTGCAGCGTCTTCCGGA TTCACTGCGAGCCGCG-3Ј, which includes the cnrX region from position 1260 to 1738. The cnrH ORF was amplified as a BamHI-PstI fragment with primers 5Ј-TTTGGATCCAATCCGGAAGACGCTGACAGAATCC-3Ј and 5-TTTGACTGCAGACTTATTTTTCCGAGTCAGCATCCAGC-3Ј, which includes the cnrH region from position 1711 to 2296. The pRSETA vector was isolated from E. coli TOP10 FЈ using a Plasmid Midi-prep kit for high-copynumber plasmids and then linearized with BamHI and PstI. Following ligation of the vector and insert, plasmid constructions were transformed into electrocompetent E. coli BL21(DE3), and transconjugants were selected on LB-AMP plates.
Production and purification of His-CnrX and His-CnrH in E. coli. Overnight cultures of E. coli BL21(DE3) bearing pRSETCnrH were diluted 100-fold into 3.3 liters of LB plus 2% (wt/vol) glucose and AMP and grown to an OD 660 of 0.5. The cells were collected by centrifugation and washed once with fresh LB-AMP medium. The cells were suspended in the same volume of fresh LB-AMP. For induction of protein overexpression, 1 mM IPTG was added and the cells were incubated for 16 h at 28°C with shaking. Subsequently, the cells were harvested by centrifugation and suspended in 50 ml of lysis buffer (500 mM NaCl, 50 mM Tris-Cl, pH 8) plus the protease inhibitors 4-(2-aminoethyl)benesulfonyl fluoride (AEBSF) (0.1 mg/ml) and leupeptin (1 g/ml). Cells were lysed by a double passage through a French pressure disruption cell. The cell pellet was recovered following centrifugation at 12,000 rpm (Sorvall centrifuge, SS34 rotor) at 4°C for 30 min. The recovered pellet was suspended in 30 ml of immobilized metal chromatography (IMAC) buffer G (6 M GdCl 2 , 50 mM Tris [pH 7.9], 0.5 M NaCl) and left on a rotary mixer for 1 h at 4°C. The denatured proteins were recovered in the supernatant fraction following centrifugation at 18,000 rpm at 4°C for 30 min using a Beckman centrifuge. The guanidine HCl-solubilized supernatant fraction was mixed with 6 ml of Ni-nitrilotriacetic acid (Ni-NTA) resin (QIAGEN, Westburg B. V., The Netherlands) in a Falcon tube and left to mix on a rotary mixer for 1 h at 4°C. The Ni-NTA resin-His-CnrH mix was packed in batch fashion into a 5-ml column (Amersham Pharmacia Biotech). The purification was carried out using the Pharmacia fast protein liquid chromatography system at 4°C. The column was washed with IMAC buffer G for 10 min at 1 ml/min until the OD 280 attained the baseline value. The adsorbed, denatured protein was allowed to slowly renaturate by the application of a 6 to 0 M GuCl 2 gradient, which was achieved by applying a continuous gradient beginning with IMAC buffer G and ending with IMAC buffer B (50 mM Tris-Cl [pH 8.0], 1 M NaCl, 20% [vol/vol] glycerol) over 4 h at 1 ml/min. His-CnrH was eluted with 10 column volumes (40 ml) of imidazole-containing IMAC buffer I (0.5 M imidazole, 1 M NaCl, 50 mM Tris-Cl, pH 7.6) at 1 ml/min. Two-milliliter fractions were collected. Fractions containing His-CnrH were pooled and further purified by gel filtration chromatography, using a Superdex 75 (16/60) Gel shift mobility assays. DNA targets were obtained by PCR amplification from pMOL28. The amplified products corresponded to the following targets: P Y fragment (positions 820 to 1028 according to Liesegang et al. [13] ), P H fragment (positions 1600 to 1800), and ivrHC fragment, containing the intervening region between cnrH and cnrC (positions 2270 to 2482). The DNA was end labeled with [␥-32 P]dATP using polynucleotide kinase (GIBCO BRL, Life Technologies N. V., Merelbeke, Belgium), according to the manufacturer's specifications. The labeled DNA was recovered using a MicroSpin column (Amersham Pharmacia Biotech) as specified by the manufacturer. The protocol of Landini et al. (12) was used as the basis for the gel shift mobility assays. Purified His-CnrH (see above) was concentrated to approximately 0.2 mg/ml (Ϸ9 M) using a Centricon instrument (Millipore, Bedford, Mass.). The protein concentration was determined spectrophotometrically at 280 nm. Reconstitution of His-CnrH with the E. coli RNA polymerase core enzyme (Biozym, Landgraaf, The Netherlands) was allowed to occur by incubation of various concentrations of HisCnrH with the core enzyme (50 nM) in vitro at 37°C for 20 min in the presence of binding buffer (50 mM Tris-Cl [pH 8], 1 mM EDTA, 1 mM dithiothreitol). The reconstituted mixture was allowed to interact with 1.5 pmol of labeled DNA (10 ng) according to the protocol of Landini et al. (12) (37°C for 30 min). Subsequently, the reaction mixture was separated on a 5% nondenaturing acrylamide gel, using 0.5ϫ Tris-borate-EDTA as the running buffer. DNA bands were visualized using autoradiography.
Primer extension for determination of mRNA transcription start sites. Total RNA extraction from the R. eutropha CH34 derivatives AE104, AE963, and AE126 was carried out using the RNeasy purification kit (QIAGEN), following the manufacturer's guide, with minor modifications for cell lysis. The CH34 derivative strains were grown in 284-gluconate medium to stationary phase and then diluted 100-fold in fresh medium and grown to an OD 660 of 0.5. The cells were induced with NiCl 2 to a final concentration of 0.4 mM for 20 min and immediately chilled on ice. The pellet was recovered by centrifugation and then resuspended in Insta-Pure solution (EUROGENTEC S. A., Seraing, Belgium) as specified by the manufacturer. Chloroform was added to 1/10 volume, and the mixture was centrifuged at 3000 rpm for 15 min (Sorvall centrifuge, Sg3 rotor). Subsequent purification steps were as specified in the QIAGEN RNeasy purification kit manual.
For the determination of transcription start sites, 40 pmol of each of the oligonucleotides, cnrYp (5Ј-GGGCCGGCTCTGCACTGATG-3Ј), cnrHp (5Ј-C GCCACAAGTTGGCCGAATG-3Ј), and cnrCp (5Ј-GCTGCAACAGGTTCG G-3Ј), was labeled using 5 l of [␥-
32 P]dATP (3,000 mCi/mmol) (Amersham) and polynucleotide kinase (New England Biolabs) by standard protocols. The final oligonucleotide concentration was adjusted to 0.8 pmol/l. For primer extension experiments, a modification of the Promega protocol was used. Hybridization was carried out using 2 pmol of the labeled primer and 10 to 20 g of total RNA extract at 45°C for 3 h in 30 l of hybridization buffer (40 mM PIPES [piperazine-N,NЈ-bis(2-ethanesulfonic acid] [pH 6.4], 400 mM NaCl, 80% formamide). The extension reaction was carried out in a 50-l volume of extension mix, containing 10 mM dithithreitol, 1ϫ First Strand Synthesis Buffer (GIBCO BRL), and 1 mM deoxynucleoside triphosphates. Superscript reverse transcriptase (GIBCO BRL, Life Technologies) (200 U) was added for extension, which was carried out for 1 h at 42°C. Following heat denaturation of the enzyme and RNase treatment, the extension products were recovered by ethanol precipitation, resuspended in formamide loading buffer, and separated on a 5% acrylamide sequencing gel next to a sequencing ladder. Sequencing reactions were carried out using the Pharmacia Amersham Biotech Thermosequenase kit according to the manufacturer's protocol for dITP cycle sequencing: the sequencing ladder of pUC18 DNA generated using the forward universal primer (5Ј-GTTTTCCCAGTCACGACGTTGTA-3Ј) was used to as a reference to mark the positions of the primer extension products, in base pairs, from the site of primer hybridization.
Construction of transcriptional fusions. Different regions of the cnr regulatory locus were amplified by PCR. EcoRI sites were introduced into the primer sequences to clone the inserts into the unique EcoRI site of pMOL877. The inserts were obtained by PCR amplification using pMOL28 DNA as a template (see Table 2 ). For the construction of point mutations within cnrYXH, a strand overlap extension protocol was used. Two primary PCRs were carried out on cnr DNA using the primer pairs CNRLUX1-PXLUX1 and CNRLUX2-PXLUX2; the resulting amplicons corresponded to the 5Ј and 3Ј ends of cnrYXH, respectively. The point mutations incorporated in PXLUX1 and PXLUX2 affected the positions 1657 (G to A), 1659 (A to G), and 1662 (T to C). This changed the presumed cnrHp promoter sequence (based on the AAC consensus for RpoElike ECF factors) from 5Ј-CCGGAACATCG-3Ј to 5Ј-CCGAAGCACCG-3Ј. The second PCR step used the products of the first PCR step as the DNA template and the primer pair CNRLUX1-CNRLUX2. Plasmid pMOL877 was isolated from CM1446 using the GIBCO BRL Plasmid Midi-prep kit for lowcopy-number plasmids. Constructs were transformed into E. coli DH10B by electroporation, and transconjugants were selected on 869 medium supplemented with 20 g of TET per ml. Plasmid DNA of transconjugants was isolated and subsequently electroporated into the R. eutropha strains AE104 and CH34. Transconjugants were selected on 869 medium supplemented with 20 g of TET per ml. Ninety-six clones were selected and inoculated onto different Ni induction plates (0.3 mM Ni), which were examined using autoradiography. Those constructs showing Ni-responsive bioluminescence (black spots on X-ray film) were further characterized.
Luminometry assays. The bioluminescence of cnr-lux constructs was measured with a LUCY1 luminometer (Anthos Labtech B.V., Heerhugowaard, The Netherlands) at 23°C. Cells were grown overnight in 869 medium plus 20 g of TET per ml to an OD 660 of 1.0. The cells were harvested by centrifugation, washed once with RM-gluconate (0.1%, wt/vol) plus MOPS and beta-glycerol phosphate, and suspended in fresh medium at an OD 660 of 0.3. Subsequently, 20 l of the metal salt solutions was added to the microtiter plates at 10ϫ the working concentrations immediately before 180 l of the test cultures was added to the well. Water was used as a negative control. The bioluminescence emitted in absolute light units (ALU) was measured over 16 h at 30-min intervals, using the MIKROWIN software of the Anthos LUCY1 luminometer. Data processing was carried out using EXCEL 7.0 (Microsoft). Constructs harboring pMOL877 in CH34 gave a noise level of approximately 100 ALU.
Nucleotide sequence accession number. The sequence of IS1087 has been entered in the EMBL database under accession no. AJ243722.
RESULTS
In vitro transcription-translation of cnrY. Based on sequence data, two possible ORFs have been hypothesized for cnrY (13) . In nccY, which is closely related to cnr, only the ORFb reading frame is present. Translational fusions of the ORFa and ORFb reading frames were constructed in the E. coli expression vector pTrc99A, resulting in pTrcCnrYa and pTrcCnrYb, respectively, and subsequently tested in an in vitro coupled transcription-translation system. As shown in Fig. 1 , both could be expressed in vitro. However, the protein product corresponding to the ORFb coding frame appeared more abundant (also by comparing the intensity of the 28-kDa internal control). Since in the homologous nccYXH system ORFa does not exist, in all likelihood the CnrY protein is translated from ORFb in vivo. It was not possible to overproduce the CnrY protein in E. coli cultures. Sequence analysis confirmed that both pTrcCnrYa and pTrcCnrYb had the correct structural integrity, and both plasmids were stably maintained in E. coli. Therefore, protein instability due to toxicity may have been the basis of this result.
Purification and characterization of CnrX. The cnrX gene was cloned in the pTrc99A expression vector, and after induction with IPTG, CnrX was over expressed in E. coli as a 16.5-kDa protein which was localized in the membrane fractions ( Fig. 2A , compare membrane fractions in lanes 2 and 3 with soluble fractions in lanes 6 and 7, respectively). In wholecell preparations of IPTG-induced cultures, a lower-molecular-mass band of approximately 14 kDa was also observed to co-migrate in SDS-polyacrylamide gels (Fig. 2A, lane 9) , which suggested that CnrX may exist as processed and nonprocessed forms, with the latter being located in the membrane fractions. The existence of a membrane-translocating leader sequence at the N terminus of CnrX, as suggested on the basis of the amino acid sequence (MMKSRTRRLSLSTLFGALLGVSVAAA  WLY [the bar represents the cleavage site, and hydrophobic residues are in boldface]), was supported by studies with pTrccnrXЈ-phoA fusions. A fusion between the N-terminal 27 amino acids of CnrX and a phoA reporter system where PhoA lacks its own signal sequence (19) resulted in strong PhoA activity; such transformants formed small, dark blue colonies when plated on selective medium (see Materials and Methods). Transformants having the pTrcCnrXЈ fused to phoA in the opposite orientation (pCnrXphoA2) did not show PhoA activity. These data are consistent with those in the accompanying study by Grass et al. (6) .
The levels of overproduction of CnrX in E. coli ( Fig. 2A ) were considered too low for isolation purposes. To improve yields, CnrX was cloned and overproduced as a histidinetagged fusion (pRSETCnrX), purified by use of Ni-NTA IMAC followed by gel filtration chromatography (Fig. 2B) . The structural integrity of the purified protein was examined by secondary structure determination using circular dichroism (unpublished data), which revealed a high alpha-helical content (37.3%) and a relatively high content of antiparallel betasheets (21.4%), features which indicate the correct folding of the protein.
Purification and characterization of CnrH. CnrH was overproduced in E. coli(pRSETCnrH) with an N-terminal histidine tag (Fig. 3) , and the resulting inclusion bodies were purified under denaturing conditions by Ni-NTA IMAC, with protein renaturation prior to elution (Fig. 3, lane 5) . Gel filtration was used as a final purification step (Fig. 3, lane 6) . The purity of the protein was quantified to be greater than 95% (as determined by reverse-phase high-pressure liquid chromatography) (data not shown). The structural integrity of the purified protein was verified by the determination of its secondary structure, which was found to include an alpha-helical content exceeding 40% (unpublished data).
CnrH is thought to be a member of the ECF 70 family. As such, CnrH should interact with a specific DNA target in the presence of core RNA polymerase. The close similarity with RpoE of E. coli prompted us to test the DNA-binding activity of His-CnrH using the core RNA polymerase of E. coli. Possible DNA targets were identified following a systematic analysis of the cnr sequence, both for regions homologous to the presumed cnrYp promoter sequence (13) and based on the consensus sequence of RpoE promoters (14) . Three fragments were identified for further studies: the P Y fragment (containing the putative cnrYp 70 -like promoter), the P H fragment (containing the putative cnrHp RpoE-like promoter), and the intervening region between cnrH and cnrC (ivrHC), showing similarity to the sequence around the presumed cnrYp promoter (6). The three potential targets were used for in vitro gel shift mobility assays. As shown in Fig. 4 , His-CnrH could retard the P Y and P H DNA fragments, but only when the core RNA polymerase enzyme of E. coli was included in the reactions. In the absence of the core RNA polymerase enzyme, no retardation was observed (results not shown). The addition of HisCnrX in the gel retardation reactions did not interrupt the interaction of His-CnrH with DNA (Fig. 4) .
Metal-responsive transcription from the regulatory locus, cnrYXHC. The transcriptional fusion of plasmid pMOL1551 was constructed by cloning the cnr regulatory locus, cnrYXHCЈ (positions 1 to 2418 according to the numbering of Liesegang et al. [13] ), upstream of the luxCDABE genes in pMOL877 (30). The transcriptional responses to nickel and cobalt were tested in the CH34 as well as the AE104 background. In the latter, no inducible bioluminescent response was observed. This indicates that additional regulatory functions are present came repressed with increasing metal concentration, and toxicity effects of the metal on the growth became apparent. The maximal transcription response was attained as a first peak during the mid-log phase and a second peak in the early stationary phase. The induction of cnr was also observed with cobalt, but the sensitivity differed from that of nickel. The maximum level of transcription was observed with cobalt concentrations of up to 2 mM.
Role of the intervening region between cnrH and cnrC (ivrHC) in metal-responsive transcription. In order to examine the effect of the intervening region between cnrH and cnrC (ivrHC), plasmid pMOL1550 was constructed. It contains the fusion cnrYXH-luxCDABE and completely lacks the ivrHC region. The transcriptional responses of pMOL1550 and pMOL1551 were compared in strain CH34(pMOL28, pMOL30). The results are presented in Fig. 5 . Nickel-dependent induction of lux in pMOL1550 and pMOL1551 showed similar kinetics. Therefore, it can be concluded that the ivrHC region is not essential for Ni-inducible regulation of transcription from the cnr regulatory locus. Neither Zn(II) nor Cr (VI) was able to induce cnrYXH transcription (data not shown). However, induction of cnr-derived transcription induced by low levels of Co 2ϩ was more efficient with pMOL1551 than with pMOL1550, indicating that the ivrHC region might play a role in low-level Co 2ϩ induction of cnrCBA transcription. However, with pMOL1596, which contains an ivrHC-lux fusion, no transcription of lux was observed in either the presence or the absence of Ni 2ϩ and Co 2ϩ (see Table 2 ). Thus, the ivrHC region is unlikely to contain a metal-inducible promoter.
Probing promoters and regulatory elements within the cnrYXH regulatory locus. Transcriptional fusions between the cnr regulatory locus and luxCDABE were constructed as shown in Table 2 . The selection of putative promoter fragments was based on the gel retardation data with CnrH. The metal responsiveness of the fusions was tested in the CH34 background, to ensure the presence of the cnrYXH genes in trans, and in the presence of 0.3 mM nickel. For comparison, transcription in the CH34 construct containing pMOL1550 was considered maximal (100% strength). As shown in Table 2 , the promoter regions P Y (in pMOL1583) and P H (in pMOL1587) were transcriptionally active, with relative signal strengths of 13 and 17%, respectively, compared to that of the complete cnrYXH fusion in pMOL1550. However, despite the presence of the CnrY, CnrX, and CnrH proteins in trans, transcription from these promoters was no longer Ni 2ϩ inducible. Interestingly, the strain containing pMOL1586 (cnrYp-cnrYX-cnrHpluxCDABE) showed metal induction kinetics for Lux comparable to that of pMOL1550. However, the maximum signal/ noise ratio was approximately one-fifth of that attained with pMOL1550, probably due to a CnrH titration effect. In pMOL1588, where cnrH is transcribed from cnrHp, transcription was maintained for 20 h (until stationary phase) at a constant, high, constitutive level (maximum signal strength, 58%). Thus, despite the presence of CnrY and CnrX in trans, transcription from cnrHp was no longer metal regulated, indicating that an additional function was required in cis. Since cnrY and cnrX, together with the promoters cnrYp and cnrHp, were able to promote an Ni 2ϩ -responsive transcription, transcriptional coupling derived from cnrYp and cnrHp might additionally be necessary for metal-dependent regulation of the cnr operon. To test this hypothesis, the cnrYp-cnrY region was oriented in the opposite direction to the cnrX-cnrHp region (Table 2 ). Induction studies showed that the transcriptional response was no longer metal inducible (compare pMOL1586 and pMOL1593). These data indicate that both promoters cnrYp and cnrHp are required in cis and must be aligned in the same direction of transcription for a metal induction response of cnr. Therefore, cnr induction by nickel (and also cobalt) is achieved by the combined activities of these two promoters. In pMOL1561, point mutations were incorporated in the putative Ϫ35 region of cnrHp; this changed the CnrX codon usage without disturbing the CnrX protein sequence, while a wildtype copy was present in addition in trans on pMOL28. The Lux phenotype became constitutive and dropped to the same level as that with pMOL1593, where transcription is directed only from the cnrYp promoter. This suggests the removal of a promoter region, as compared to the case with pMOL1550.
Genetic analysis of the ZinB phenotype. To complete the characterization of mutant phenotypes affected in cnr regulation, the genetic basis of the ZinB phenotype (1) was investigated. In strain AE963, nickel and cobalt resistances are constitutive and accompanied by a low-level zinc resistance that is probably due to overexpression of the cnr structural resistance proteins (1) . Comparison of the EcoRI digests of pMOL28 from AE126 and pMOL29 from AE963 showed that in the latter, the EcoRI fragment bearing the cnr operon was approximately 1 kb larger than in the original pMOL28 (unpublished data). Further restriction analyses showed that an insertion in the cnrY gene was responsible for the observed ZinB mutant phenotype. Sequencing analysis revealed the presence of an IS2-type insertion element, which was designated IS1087.
Transcription start sites. The transcription start sites in cnr mRNA on induction with nickel were determined by primer extension. As shown in Fig. 6A , extension products were obtained in AE126 with both the cnrYp-and cnrHp-specific primers. No extension product with the ivrHC primer (corresponding to the presumed cnrCp promoter [6] ) was observed. The cnrYp extension product corresponded to a distance of 133 nucleotides from the site where the pUC18 universal primer hybridized to its template. The deduced transcription start is therefore 5Ј-T 949 ATAAGAGGCAATGGATCTGGATG (the ϩ1 nucleotide A 959 is underlined). The cnrHp extension product corresponded to a distance of 101 nucleotides from the site where the primer hybridized, with the deduced start site being 5Ј-T 1683 CTTATCGATGC (the ϩ1 G 1693 is underlined). In AE963 (cnrY963::IS1087), no extension product was obtained with either the cnrYp or the ivrHC primers, while a strong signal was observed at the same position with the cnrHp primer as in AE126. An additional extension product was detected which would correspond to a transcription start 5Ј-T 1683 CTT ATCGATGCACTACG. Since the cnrYp promoter is located upstream of the IS1087 insertion point in cnrY (position 1036), this also proves that no promoter from which transcription of the cnr structural genes occurs is present on IS1087. Therefore, the constitutive cnr expression in AE963 is due to transcription from the cnrHp promoter. No signals were obtained with the plasmid-free control strain, AE104.
DISCUSSION
Since the early report on the nucleotide sequence of the cnr cobalt and nickel resistance operon of the R. eutropha-like strain CH34 by Liesegang et al. (13) , the regulation of this resistance determinant has remained a mystery. In addition, the novelty of this regulatory locus, compared to well-characterized systems, at the genetic and protein levels has contributed to the slow advances made. In this paper, the roles of the individual components of the cnr regulatory region are examined.
The first determinant examined was cnrY, which is immediately preceded by the cnrYp promoter. Our findings point to ORFb (13) as being the correct ORF for cnrY, and this is further supported by the strong similarity of ORFb with nccY (where only one ORF exists). Furthermore, the ATG translation start of the putative protein ORFb is 6 nucleotides from the proposed ribosome-binding site, while no ribosome-binding site for ORFa translation could be identified (13) . The CnrY protein is thought to have a downregulating role, based on cnrY963::IS1087, displaying a zinc-resistant (ZinB) phenotype. In this mutant, IS1087 is inserted at position 1036 in cnrY and disrupts the CnrY protein close to the N terminus. The resulting phenotype is low-level zinc resistance and elevated constitutive resistance to both cobalt and nickel, suggesting the inactivation of a repressor (1, 13) . In primer extension assays with the cnrYp primer, no fragment was obtained with mRNA of strain AE963, showing that there is no promoter activity from IS1087 in the direction of cnrXH. It was not possible to overproduce the CnrY protein in vivo in E. coli; this is commonly encountered for negative regulators, which can confer toxicity to host cells on overproduction. CnrY, a 95-amino-acid protein (13) (for the revised sequence, see reference 6), shows no homology to well-characterized proteins in the database, except the homologous NccY. There are no obvious motifs in the primary amino acid structure of CnrY. However, the predicted secondary structure suggests two potential transmembrane domains towards the C terminus of the protein, a feature which was confirmed by use of phoA fusions (6) . It is therefore possible that CnrY could be a negative regulator acting at the level of the cytoplasmic membrane. There are no obvious DNA-binding motifs in CnrY or obvious operator regions within cnrYXH, and therefore it is difficult to assign the protein a role as a DNA-binding repressor (13) . Nevertheless, a putative role as an anti-sigma factor against CnrH can be envisaged, since many ECF sigma factors are controlled by a small, membrane-bound protein which is produced in stoichiometric proportions and which ensures a rapid on-off switch of sigma activity (10, 11) . For cnrY963::IS1087 in AE963, transcription from cnrYp is disrupted. Therefore, high-level constitutive transcription in ZinB mutants must be due to transcription from a promoter downstream of cnrY, since there are no candidate promoter sequences within IS1087 in the direction of cnrXH, and no transcripts were identified by primer extension studies. In the accompanying study by Grass et al. (6) , a similar (but not identical) constitutive, elevated resistance phenotype due to a frameshift mutation in cnrY resulting from a gene duplication of 14 bp mediated by an insertion sequence element is described. This supports the hypothesis that high-level transcription of cnrCBA is directed from another promoter downstream of cnrYp and that it is the combination of a disrupted CnrY protein and uncoupling of cnrYp and a downstream promoter which give rise to the constitutive, elevated nickel resistance. The localization of this promoter is discussed below. CnrH, a 21-kDa protein, belongs to a family of ECF 70 -like proteins that direct the specific transcription of signals generated outside the cytoplasmic boundaries (14) . The closest homologs of CnrH are the NccH (65% identity) and RpoE (32% identity) of E. coli. As with other 70 -like factors, there is a prominent helix-turn-helix motif at the carboxy terminus of CnrH (14) . Purified His-CnrH, with an N-terminal histidine tag, in the presence of core RNA polymerase of E. coli could bind DNA targets containing the presumed cnrYp and cnrHp promoters. The DNA targets were confirmed to display promoter activities in lux-based transcription studies, and the corresponding promoter transcription start sites were identified using primer extension. It is interesting that the two promoter DNA targets have quite different sequences (13) . In vitro, the P Y promoter region was retarded by purified His-CnrH. Therefore, it is expected that in vivo CnrH would also transcribe cnr from the cnrYp promoter. Interestingly, the ivrHC region, whose sequence includes a region similar to the Ϫ10 region of cnrYp, was not retarded in in vitro DNA-binding assays. Furthermore cnr-lux transcriptional fusions incorporating (pMOL1551) and lacking (pMOL1550) this region showed similar Lux induction kinetics in the presence of Ni 2ϩ , while an ivrHC-lux fusion (pMOL1596) showed a background activity in strain CH34. Also, no promoter in this region could be identified by the primer extension experiments. The activity of cnrHp in the presence of metal was confirmed in primer extension assays, which contradicts the findings of Grass et al. (6) , who were not able to detect a transcription start site from this region, although a downstream start site was reported originating from the ivrHC region (cnrCp promoter). Nonetheless, the observation of reverse transcriptase PCR products for the intervening region of cnrH and cnrC, as described by Grass et al. (6) , also further supports a possible cnrHCBA transcript. The presumed cnrHp sequence resembles closely that of the RpoE promoter consensus and closely fits the common Ϫ35 . . . . . AAC. . . . . consensus proposed for the ECF family. The location of cnrHp within the cnrX coding region was confirmed by mutating the Ϫ35 . . . . . AAC. . . . . sequence without affecting the amino acid sequence of cnrX. A lux fusion of the mutated cnrHp no longer had a metal-inducible Lux ϩ phenotype, indicating that the mutation completely inactivated the promoter activity of the P H region. Thus, the . . . . . AAC. . . . . sequence is indeed part of the cnrHp promoter. It is not unknown for ECFs to recognize different promoter sequences. Since the assembly of the RNA polymerase holoenzyme involves a complex interaction between the sigma factor, core, and DNA, it is conceivable that CnrH is recruited by one type of core RNA polymerase to direct transcription from cnrYp and by another type for transcription from cnrHp.
The role of cnrX in regulation has been the most intriguing. Metal resistance in a CnrX Ϫ mutant was constitutively expressed, without affecting the level of resistance (13) . It therefore appears that CnrX is not essential for the resistance phenotype (13) . However the transcription data suggest that this locus is required for metal-inducible transcription from cnrYp and cnrHp. It has been postulated that CnrX functions as an anti-sigma factor on CnrH. However, our results do not support this hypothesis, since the binding of CnrH to the cnrYp fragment was not affected by the addition of purified HisCnrX. The N-terminal domain of CnrX is quite hydrophobic and has features of a leader peptide. CnrX overproduced in E. coli fractionated predominantly in the membrane fractions, although in whole-cell cultures a lower-molecular-weight form was also evident. This would indicate an inefficient processing of a signal sequence. PhoA fusions confirmed that the CnrX N terminus would function as a leader sequence. The topological orientation of the CnrX C terminus would therefore be periplasmic, which is corroborated by the findings of by Grass et al. (6) , who found that the CnrX C terminus induced high alkaline phosphatase activities in phoA reporter fusions. CnrX contains six histidine residues, whose spatial arrangement in the primary amino acid sequence is identically conserved in NccX. The cluster of these residues together with the numerous glutamate residues may constitute important metal-binding sites in the protein. Therefore, CnrX may function as a periplasmic metal-sensing protein, interacting with CnrY, which is also localized at the membrane (6).
In conclusion, the cnr regulation appears to be effected by the activities of at least two promoters, cnrYp and cnrHp, whose presence was confirmed by gel retardation studies, primer extension, and transcriptional fusions. The cnrHp promoter, located within the cnrX coding region, is associated with high-level activity and is therefore likely to promote the high levels of transcription observed in the presence of metal. The cnrYp promoter is also transcriptionally active, but with a lower promoter strength than cnrHp. CnrH recognizes both promoter regions in complex with the core RNA polymerase, and the combined activities of both promoters are necessary for metal-responsive transcription of the cnr operon. ivrHC, which is not recognized by CnrH and seems indispensable for Niinduced cnrCBA transcription, nevertheless seems to be required for optimal transcription when low levels of Co 2ϩ are present. CnrY might function as a repressor or anti-sigma factor, and CnrX might function as a periplasmic sensor. Clearly, further studies on the in vivo preferences of the cnr promoters in the presence and absence of metal will be required if a model of regulation is to be hypothesized.
